Cross Country Healthcare Swings to Loss Amid Revenue Drop, Merger Uncertainty

Ticker: CCRN · Form: 10-Q · Filed: 2025-11-12T00:00:00.000Z

Sentiment: bearish

Topics: Healthcare Staffing, Mergers & Acquisitions, Regulatory Risk, Government Shutdown Impact, Net Loss, Revenue Decline, FTC Review

Related Tickers: CCRN, AMN, RHI

TL;DR

**CCRN is bleeding cash and facing a make-or-break merger deadline; get out before the December 3rd cliff.**

AI Summary

CROSS COUNTRY HEALTHCARE INC (CCRN) reported a significant decline in financial performance for the three and nine months ended September 30, 2025, primarily driven by reduced revenue and increased acquisition-related costs. Revenue from services decreased by 20.6% to $250.05 million for the three months ended September 30, 2025, compared to $315.12 million in the prior year. For the nine months, revenue fell by 20.9% to $817.53 million from $1.03 billion. The company swung to a net loss of $4.77 million for the three months, a stark contrast to a net income of $2.56 million in the same period of 2024. The nine-month net loss deepened to $11.92 million from $10.80 million. A key business change is the pending Aya Merger, which incurred $4.1 million in acquisition and integration-related costs for the quarter and $12.2 million year-to-date. Risks include delays in the Aya Merger due to the U.S. government shutdown impacting FTC review, potential termination of the Merger Agreement by December 3, 2025, and the general macroeconomic environment with increased inflation and interest rates. The strategic outlook is dominated by the uncertainty of the Aya Merger's completion, which would take CCRN private.

Why It Matters

This filing reveals significant operational headwinds for Cross Country Healthcare, with substantial revenue declines and a shift to net losses. For investors, the primary concern is the highly uncertain Aya Merger; its potential failure by December 3, 2025, could lead to a significant stock price correction, especially given the $12.2 million in merger-related costs already incurred. Employees face uncertainty regarding job security and organizational structure if the merger proceeds or fails. Customers might experience service disruptions or changes in provider relationships depending on the merger's outcome. In the broader market, this highlights the challenges in the healthcare staffing sector and the impact of regulatory delays (like the FTC review during a government shutdown) on M&A activity, potentially affecting competitive dynamics.

Risk Assessment

Risk Level: high — The risk level is high due to the significant uncertainty surrounding the Aya Merger. The HSR waiting period is now set to expire after the December 3, 2025, end date of the Merger Agreement due to the U.S. government shutdown, creating a high probability of termination if an extension isn't agreed upon. Furthermore, the company reported a net loss of $4.77 million for the three months ended September 30, 2025, a substantial decline from a $2.56 million net income in the prior year, indicating deteriorating operational performance.

Analyst Insight

Investors should consider divesting their CCRN shares given the high risk of the Aya Merger failing by the December 3, 2025, deadline. The company's deteriorating financial performance, evidenced by a $4.77 million net loss for the quarter, further underscores the precarious position. Await clear communication on the merger extension or termination before considering any new positions.

Financial Highlights

debt To Equity
0.32
revenue
$250.05M
operating Margin
-2.39%
total Assets
$538.23M
total Debt
$130.09M
net Income
($4.77M)
eps
N/A
gross Margin
N/A
cash Position
$99.13M
revenue Growth
-20.6%

Revenue Breakdown

SegmentRevenueGrowth
Revenue from services$250.05M-20.6%
Revenue from services$817.53M-20.9%

Key Numbers

Key Players & Entities

FAQ

What were Cross Country Healthcare's revenues for the quarter ended September 30, 2025?

Cross Country Healthcare's revenue from services for the three months ended September 30, 2025, was $250.05 million, a decrease from $315.12 million in the same period of 2024.

Did Cross Country Healthcare report a profit or loss in Q3 2025?

Cross Country Healthcare reported a net loss attributable to common stockholders of $4.77 million for the three months ended September 30, 2025, compared to a net income of $2.56 million in Q3 2024.

What is the status of the Aya Merger for Cross Country Healthcare?

The Aya Merger is pending, but the HSR waiting period is now set to expire after the current December 3, 2025, end date of the Merger Agreement due to the U.S. government shutdown impacting the FTC review. The Company and Aya are discussing an extension.

What are the key risks associated with the Aya Merger for CCRN?

Key risks include the potential for the Merger Agreement to be terminated if an extension beyond December 3, 2025, is not reached, the diversion of management time, and adverse effects on CCRN's market price, customer retention, and key personnel if the merger fails.

How much did Cross Country Healthcare spend on acquisition-related costs in the first nine months of 2025?

Cross Country Healthcare incurred $12.18 million in acquisition and integration-related costs for the nine months ended September 30, 2025, primarily associated with the pending Aya Merger.

What is the impact of the U.S. government shutdown on the Aya Merger?

The U.S. government shutdown has closed the FTC, extending the HSR waiting period day-for-day. This means the waiting period is now expected to expire after the current December 3, 2025, end date of the Merger Agreement, creating a critical timing issue.

What is Cross Country Healthcare's cash position as of September 30, 2025?

As of September 30, 2025, Cross Country Healthcare had cash and cash equivalents of $99.13 million, an increase from $81.63 million at December 31, 2024.

What does the term 'Second Request' mean in the context of the Aya Merger?

A 'Second Request' from the FTC is a request for additional information in connection with their antitrust review under the Hart-Scott-Rodino Act, indicating a more in-depth investigation into the proposed merger.

How has Cross Country Healthcare's stock repurchase activity changed?

For the nine months ended September 30, 2025, stock repurchase and retirement was only $0.31 million, a significant decrease from $33.23 million in the same period of 2024, reflecting a shift in capital allocation likely due to the pending merger.

What are the macroeconomic risks mentioned by Cross Country Healthcare?

Cross Country Healthcare cited macroeconomic factors such as increased inflation and interest rates, uncertain or reduced demand for healthcare services, and potential delays in payments from customers as risks to its future results of operations and liquidity.

Risk Factors

Industry Context

The healthcare staffing industry is highly competitive and sensitive to macroeconomic conditions. Companies like Cross Country Healthcare (CCRN) face challenges from inflation, interest rate hikes, and regulatory scrutiny, particularly concerning mergers and acquisitions. The ongoing demand for healthcare professionals remains a backdrop, but operational efficiency and strategic execution are critical for navigating these headwinds.

Regulatory Implications

The pending Aya Merger is subject to FTC review, which has been impacted by government shutdowns, creating significant regulatory uncertainty. Delays or failure to obtain regulatory approval could have substantial financial and strategic consequences for CCRN.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Acquisition and integration-related costs
Expenses incurred specifically due to the process of acquiring another company and integrating its operations. (These costs, totaling $4.1 million for Q3 2025 and $12.2 million year-to-date, are negatively impacting CCRN's profitability due to the pending Aya Merger.)
Retained earnings
The cumulative amount of net income that a company has kept over time, rather than distributing to shareholders as dividends. (A decrease in retained earnings from $218.06M to $206.14M indicates that the company has experienced net losses or paid out dividends, impacting its accumulated profitability.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (The consistent $135.06M in goodwill suggests no impairment charges related to past acquisitions, but it represents a significant portion of the company's assets.)
Operating lease right-of-use assets
Assets recognized under accounting standards for leases, representing the right to use an underlying asset for the lease term. (These assets have decreased, indicating a reduction in the company's leased facilities or equipment, potentially related to restructuring or cost-saving measures.)
Accumulated other comprehensive loss
A component of equity that includes unrealized gains and losses on certain investments and foreign currency translations that are not included in net income. (A slight increase in the loss from ($1.44M) to ($1.53M) suggests minor negative impacts from items outside of core operations.)

Year-Over-Year Comparison

Compared to the prior year, Cross Country Healthcare Inc. has experienced a significant downturn in financial performance. Revenue from services declined by 20.6% for the third quarter and 20.9% for the nine-month period ended September 30, 2025. This revenue drop has led to a swing from a net income of $2.56 million in Q3 2024 to a net loss of $4.77 million in Q3 2025. The nine-month net loss also deepened. New risks have emerged, primarily related to the pending Aya Merger, including FTC review delays due to government shutdowns and the potential termination of the merger agreement, alongside ongoing macroeconomic concerns.

Filing Stats: 4,640 words · 19 min read · ~15 pages · Grade level 18.7 · Accepted 2025-11-12 17:06:35

Key Financial Figures

Filing Documents

– FINANCIAL INFORMATION

PART I. – FINANCIAL INFORMATION 1 Item 1. Condensed Consolidated Financial Statements 1 Condensed Consolidated Balance Sheets (Unaudited) 1 Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) 2 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) 3 Condensed Consolidated Statements of Cash Flows (Unaudited) 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 39 Item 4.

Controls and Procedures

Controls and Procedures 39

– OTHER INFORMATION

PART II. – OTHER INFORMATION 40 Item 1.

Legal Proceedings

Legal Proceedings 40 Item 1A.

Risk Factors

Risk Factors 40 Item 5. Other Information 41 Item 6. Exhibits 42

Signatures

Signatures 43 i

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CROSS COUNTRY HEALTHCARE, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, amounts in thousands) September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 99,132 $ 81,633 Accounts receivable, net of allowances of $ 9,162 in 2025 and $ 9,301 in 2024 180,208 223,238 Income taxes receivable 3,760 10,389 Prepaid expenses 5,289 7,848 Insurance recovery receivable 5,632 9,255 Other current assets 1,092 2,637 Total current assets 295,113 335,000 Property and equipment, net of accumulated depreciation of $ 25,547 in 2025 and $ 19,285 in 2024 28,269 28,850 Operating lease right-of-use assets 1,851 2,468 Goodwill 135,060 135,060 Other intangible assets, net 35,523 42,186 Deferred tax assets 9,460 8,104 Insurance recovery receivable 14,893 20,928 Cloud computing 12,855 10,846 Other assets 5,207 5,809 Total assets $ 538,231 $ 589,251 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses $ 42,311 $ 64,946 Accrued compensation and benefits 41,856 47,646 Operating lease liabilities 846 2,089 Earnout liability — 4,411 Other current liabilities 531 1,310 Total current liabilities 85,544 120,402 Operating lease liabilities 1,358 1,782 Accrued claims 29,266 34,425 Uncertain tax positions 10,346 10,117 Other liabilities 3,575 3,566 Total liabilities 130,089 170,292 Commitments and contingencies Stockholders' equity: Common stock 3 3 Additional paid-in capital 203,529 202,338 Accumulated other comprehensive loss ( 1,526 ) ( 1,441 ) Retained earnings 206,136 218,059 Total stockholders' equity 408,142 418,959 Total liabilities and stockholders' equity $ 538,231 $ 589,251 See accompanying notes to the condensed consolidated financial statements 1 CROSS COUNTRY HEALTHCARE, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (Unaudited, amounts in thousands, except

View on Read The Filing